THE STATE OF THE PROTEOLYSIS SYSTEM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA ON THE BACKGROUND OF DIABETES MELLITUS TYPE 2

DOI: https://doi.org/10.29296/24999490-2020-02-11

D.A. Dyakov, O.E. Akbasheva, A.A. Zaitsevа, I.S. Zavaruev, I.Yu. Shuvalov Siberian State Medical University, Tomsk, Moskovsky trakt, 2, Tomsk, 634055, Russian Federation E-mail: [email protected]

Introduction. The progression of inflammation in community-acquired pneumonia is associated with the activation of proteolytic enzymes, involved in eliminating the pathogenic agent, removing damaged structures. Proteinases are controlled by α1-proteinase inhibitor. It is known that in diabetes mellitus (DM) patients as a consequence of microangiopathy, the target for damage is pulmonary tissue, which is accompanied by the risk of developing bronchial asthma, pneumonia. In pneumonia on the background of type 2 diabetes there are poorly expressed symptoms or atypical course of the disease is shown. Therefore, it is promising to search for biochemical indices allowing to identify the features of the course of community-acquired pneumonia on the background of DM type 2. The aim of the study is to evaluate the level of elastase -, trypsin-like proteases and α1-PI in the blood plasma of patients with community- acquired pneumonia, DM type 2, as well as in the group of patients with combined pathology of pneumonia and DM type 2. Results: level of α1-PI was maximal in community-acquired pneumonia and amounted to 43.9 МE/ml. The maximum increase of elastase-and trypsin-like proteinases level is observed in the group with combined pathology of pneumonia with DM type 2 and accounts for 145.3 nmol BANE/min•ml and 151.6 nmol BAEE / min·ml, respectively. Conclusion. Pneumonia on the background of DM type 2 occurs most acutely with pronounced destructive processes of the lung tissue, due to a violation of the balance of «proteolysis-anti-proteolysis».
Keywords: 
diabetes, proteolysis

Список литературы: 
  1. Song S., Lu Y., Elshikha A.S. In vivo analy- sis of Alpha-1-Antitrypsin functions in autoimmune disease models. Methods Mol. Biol. 2018; 1826: 143–55. http://doi. org/10.1007/978-1-4939-8645-3_10.
  2. Bereznjakov I.G. Osobennosti techenija vnebol'nichnoj pnevmonii u patsientov s saharnym diabetom 2 tipa. Zhurnal klinicheskih i eksperimental'nyh meditsinskih issledovanij. 2013; 2: 112–20. [Bereznjakov I.G. Features of the course of community-acquired pneumonia in patients with type 2 diabetes, Zhurnal klin- icheskih i jeksperimental’nyh medicinskih issledovanij. 2013; 2: 112–20]
  3. Poteryaeva O.N., Russkich G.S., Panin L.E. Analysis of serum activities of matrix metalloproteinases and α1-proteinase inhibitor in patients with type 2 diabetes mellitus. Bull. Exp. Biol. Med. 2015; 152 (5): 578–9.
  4. Abboud R.T., Vimalanathan S. Pathogen- esis of COPD. Part I. The role of protease- antiprotease imbalance in emphysema. Int. J. Tuberc. Lung Dis. 2008; 12 (4): 361–67.
  5. Martins M., Boavida J.M., Raposo J.F., Froes F., Nunes B. Diabetes hinders community- acquired pneumonia outcomes in hospi- talized patients. BMJ Open Diabetes Res. Care. 2016; 4 (1). http://doi.org/10.1136/ bmjdrc-2015-000181.
  6. Li Y., Krowka M.J., Qi Y. Alpha1-antitrypsin deficiency carriers, serum alpha 1-antit- rypsin concentration, and non-small cell lung cancer survival. J. Thorac Oncol. 2014; 6 (2): 291–5. http://doi.org/10.1097/ JTO.0b013e31820213fb.
  7. Zhao P., Lieu T., Barlow N., Sostegni S. Neutrophil elastase activates protease- activated receptor-2 (PAR2) and transient receptor potential vanilloid 4 (TRPV4) to cause inflammation and pain. J. Biol. Chem. 2015; 290 (22): 13875–87.
  8. Janciauskiene S., Tumpara S., Wiese M., Wrenger S. Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysi- ological significance. J. Leukoc Biol. 2017; 102 (4): 1127–41. http://doi.org/10.1189/ jlb.3A0317-124R.
  9. Akbasheva O.E., D'jakov D.A. Sostojanie i vzaimosvjaz' sistemy proteoliza so svobodnoradikal'nym okisleniem lipidov pri saharnom diabete II tipa. V sbornike: Novaja nauka: novye vyzovy II Mezhdunarodnaja nauchno- prakticheskaja konferentsija. 2018; 6–13. [Akbasheva O.E., D’yakov D.A. State and interrelation of proteolysis system with free radical lipid oxidation in type II diabetes mellitus, V sbornike: Novaja nauka: novye vyzovy II Mezhdunarodnaja nauchno- prakticheskaja konferencija. 2018; 6–13 (in Russian)]